Imaging of Dopaminergic System in Movement Disorders / 핵의학분자영상
Nuclear Medicine and Molecular Imaging
;
: 132-140, 2007.
Artigo
em Coreano
| WPRIM
| ID: wpr-225213
ABSTRACT
Parkinson's disease is a common neurodegenerative disorder that is mainly caused by dopaminergic neuron loss in the substantia nigra. Several radiopharmaceutics have been developed to evaluate the integrity of dopaminergic neuronal system. In vivo PET and SPECT imaging of presynaptic dopamine imaing are already applied to Parkinson's disease and other parkinsonism, and can demonstrate the dopaminergic dysfunction. This review summarized the use of the presynaptic dopaminergic imaging in PD as biomarkers in evaluation of disease progression as well as in diagnosis of PD.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Doença de Parkinson
/
Substância Negra
/
Biomarcadores
/
Dopamina
/
Tomografia Computadorizada de Emissão de Fóton Único
/
Progressão da Doença
/
Doenças Neurodegenerativas
/
Transtornos Parkinsonianos
/
Diagnóstico
/
Neurônios Dopaminérgicos
Tipo de estudo:
Estudo diagnóstico
Idioma:
Coreano
Revista:
Nuclear Medicine and Molecular Imaging
Ano de publicação:
2007
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS